Annual EBITDA:
$583.00M+$225.00M(+62.85%)Summary
- As of today, NBIX annual EBITDA is $583.00 million, with the most recent change of +$225.00 million (+62.85%) on December 31, 2024.
- During the last 3 years, NBIX annual EBITDA has risen by +$444.90 million (+322.16%).
- NBIX annual EBITDA is now at all-time high.
Performance
NBIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$247.00M+$94.10M(+61.54%)Summary
- As of today, NBIX quarterly EBITDA is $247.00 million, with the most recent change of +$94.10 million (+61.54%) on September 30, 2025.
- Over the past year, NBIX quarterly EBITDA has increased by +$55.70 million (+29.12%).
- NBIX quarterly EBITDA is now at all-time high.
Performance
NBIX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$583.30M+$55.70M(+10.56%)Summary
- As of today, NBIX TTM EBITDA is $583.30 million, with the most recent change of +$55.70 million (+10.56%) on September 30, 2025.
- Over the past year, NBIX TTM EBITDA has dropped by -$30.70 million (-5.00%).
- NBIX TTM EBITDA is now -5.00% below its all-time high of $614.00 million, reached on September 30, 2024.
Performance
NBIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NBIX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +62.9% | +29.1% | -5.0% |
| 3Y3 Years | +322.2% | +169.1% | +160.6% |
| 5Y5 Years | +578.7% | +223.3% | +67.0% |
NBIX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +322.2% | at high | +689.1% | -5.0% | +160.6% |
| 5Y | 5-Year | at high | +578.7% | at high | +3759.4% | -5.0% | +225.3% |
| All-Time | All-Time | at high | +387.4% | at high | +410.9% | -5.0% | +365.3% |
NBIX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $247.00M(+61.5%) | $583.30M(+10.6%) |
| Jun 2025 | - | $152.90M(+388.5%) | $527.60M(-0.4%) |
| Mar 2025 | - | $31.30M(-79.4%) | $529.90M(-13.1%) |
| Dec 2024 | $583.00M(+62.8%) | $152.10M(-20.5%) | $610.10M(-0.6%) |
| Sep 2024 | - | $191.30M(+23.3%) | $614.00M(+7.8%) |
| Jun 2024 | - | $155.20M(+39.2%) | $569.40M(+15.5%) |
| Mar 2024 | - | $111.50M(-28.5%) | $492.90M(+18.5%) |
| Dec 2023 | $358.00M(+51.3%) | $156.00M(+6.3%) | $416.10M(+12.6%) |
| Sep 2023 | - | $146.70M(+86.4%) | $369.60M(+17.4%) |
| Jun 2023 | - | $78.70M(+126.8%) | $314.70M(+6.8%) |
| Mar 2023 | - | $34.70M(-68.3%) | $294.60M(+10.6%) |
| Dec 2022 | $236.60M(+71.3%) | $109.50M(+19.3%) | $266.30M(+19.0%) |
| Sep 2022 | - | $91.80M(+56.7%) | $223.80M(+24.8%) |
| Jun 2022 | - | $58.60M(+815.6%) | $179.30M(-6.2%) |
| Mar 2022 | - | $6.40M(-90.4%) | $191.10M(-12.6%) |
| Dec 2021 | $138.10M(-6.8%) | $67.00M(+41.6%) | $218.70M(-3.1%) |
| Sep 2021 | - | $47.30M(-32.8%) | $225.70M(-11.4%) |
| Jun 2021 | - | $70.40M(+107.1%) | $254.80M(-17.6%) |
| Mar 2021 | - | $34.00M(-54.1%) | $309.10M(-8.0%) |
| Dec 2020 | $148.10M(+72.4%) | $74.00M(-3.1%) | $336.10M(-3.7%) |
| Sep 2020 | - | $76.40M(-38.7%) | $349.19M(-4.3%) |
| Jun 2020 | - | $124.70M(+104.4%) | $364.90M(+29.7%) |
| Mar 2020 | - | $61.00M(-30.0%) | $281.44M(+20.2%) |
| Dec 2019 | $85.90M(+52.6%) | $87.09M(-5.4%) | $234.09M(+37.6%) |
| Sep 2019 | - | $92.11M(+123.3%) | $170.15M(+27.5%) |
| Jun 2019 | - | $41.25M(+202.2%) | $133.45M(+46.3%) |
| Mar 2019 | - | $13.65M(-41.0%) | $91.23M(+123.0%) |
| Dec 2018 | $56.30M(+146.7%) | $23.15M(-58.2%) | $40.92M(+35.0%) |
| Sep 2018 | - | $55.40M(+5817.5%) | $30.31M(+199.5%) |
| Jun 2018 | - | -$969.00K(+97.4%) | -$30.47M(+64.6%) |
| Mar 2018 | - | -$36.66M(-392.4%) | -$86.18M(+33.2%) |
| Dec 2017 | -$120.62M(+13.6%) | $12.54M(+333.1%) | -$128.96M(+31.1%) |
| Sep 2017 | - | -$5.38M(+90.5%) | -$187.26M(+14.8%) |
| Jun 2017 | - | -$56.68M(+28.7%) | -$219.91M(-7.4%) |
| Mar 2017 | - | -$79.44M(-73.6%) | -$204.73M(-40.4%) |
| Dec 2016 | -$139.64M(-58.8%) | -$45.76M(-20.3%) | -$145.87M(-11.7%) |
| Sep 2016 | - | -$38.03M(+8.4%) | -$130.59M(-1.9%) |
| Jun 2016 | - | -$41.50M(-101.7%) | -$128.16M(-14.7%) |
| Mar 2016 | - | -$20.58M(+32.5%) | -$111.73M(-19.9%) |
| Dec 2015 | -$87.92M(-38.3%) | -$30.48M(+14.4%) | -$93.19M(-12.3%) |
| Sep 2015 | - | -$35.60M(-42.0%) | -$82.96M(-29.6%) |
| Jun 2015 | - | -$25.07M(-1126.6%) | -$64.00M(-20.6%) |
| Mar 2015 | - | -$2.04M(+89.9%) | -$53.08M(+16.5%) |
| Dec 2014 | -$63.58M(-29.7%) | -$20.24M(-21.7%) | -$63.58M(-16.2%) |
| Sep 2014 | - | -$16.64M(-17.6%) | -$54.71M(-9.6%) |
| Jun 2014 | - | -$14.15M(-12.8%) | -$49.91M(-2.4%) |
| Mar 2014 | - | -$12.55M(-10.3%) | -$48.75M(+0.5%) |
| Dec 2013 | -$49.01M(-2428.1%) | -$11.37M(+3.9%) | -$49.01M(-69.7%) |
| Sep 2013 | - | -$11.84M(+8.9%) | -$28.88M(-38.6%) |
| Jun 2013 | - | -$12.99M(-1.5%) | -$20.84M(-130.1%) |
| Mar 2013 | - | -$12.80M(-246.2%) | -$9.05M(-530.2%) |
| Dec 2012 | $2.10M(-93.9%) | $8.76M(+330.5%) | $2.10M(+134.7%) |
| Sep 2012 | - | -$3.80M(-212.9%) | -$6.07M(-121.5%) |
| Jun 2012 | - | -$1.21M(+26.0%) | $28.22M(-8.1%) |
| Mar 2012 | - | -$1.64M(-381.8%) | $30.70M(-11.3%) |
| Dec 2011 | $34.62M(+381.8%) | $582.00K(-98.1%) | $34.62M(-5.4%) |
| Sep 2011 | - | $30.49M(+2300.9%) | $36.61M(+304.5%) |
| Jun 2011 | - | $1.27M(-44.3%) | $9.05M(+279.4%) |
| Mar 2011 | - | $2.28M(-11.4%) | $2.39M(+125.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$12.29M(+74.4%) | $2.57M(-12.2%) | -$9.49M(+53.4%) |
| Sep 2010 | - | $2.93M(+154.3%) | -$20.34M(+36.7%) |
| Jun 2010 | - | -$5.40M(+43.8%) | -$32.15M(+21.2%) |
| Mar 2010 | - | -$9.59M(-15.8%) | -$40.77M(+8.4%) |
| Dec 2009 | -$47.93M(+35.2%) | -$8.28M(+6.7%) | -$44.51M(+10.3%) |
| Sep 2009 | - | -$8.88M(+36.7%) | -$49.62M(+8.9%) |
| Jun 2009 | - | -$14.02M(-5.2%) | -$54.48M(+7.0%) |
| Mar 2009 | - | -$13.33M(+0.5%) | -$58.58M(+8.4%) |
| Dec 2008 | -$73.98M(+63.5%) | -$13.40M(+2.4%) | -$63.95M(+15.9%) |
| Sep 2008 | - | -$13.73M(+24.2%) | -$76.07M(+14.5%) |
| Jun 2008 | - | -$18.12M(+3.1%) | -$88.95M(+7.3%) |
| Mar 2008 | - | -$18.70M(+26.8%) | -$95.92M(+5.9%) |
| Dec 2007 | -$202.84M(-97.4%) | -$25.53M(+4.1%) | -$101.94M(-13.1%) |
| Sep 2007 | - | -$26.61M(-6.1%) | -$90.09M(+1.6%) |
| Jun 2007 | - | -$25.08M(-1.5%) | -$91.54M(+1.6%) |
| Mar 2007 | - | -$24.71M(-80.6%) | -$93.04M(+0.2%) |
| Dec 2006 | -$102.75M(-586.0%) | -$13.68M(+51.2%) | -$93.25M(+8.2%) |
| Sep 2006 | - | -$28.07M(-5.6%) | -$101.56M(-121.6%) |
| Jun 2006 | - | -$26.57M(-6.6%) | -$45.83M(-99.2%) |
| Mar 2006 | - | -$24.93M(-13.4%) | -$23.00M(-53.6%) |
| Dec 2005 | -$14.98M(+66.9%) | -$21.99M(-179.5%) | -$14.98M(-25.9%) |
| Sep 2005 | - | $27.66M(+838.3%) | -$11.89M(+70.6%) |
| Jun 2005 | - | -$3.75M(+77.8%) | -$40.50M(+16.8%) |
| Mar 2005 | - | -$16.91M(+10.6%) | -$48.67M(-7.6%) |
| Dec 2004 | -$45.25M(+17.9%) | -$18.91M(-1913.4%) | -$45.25M(-5.4%) |
| Sep 2004 | - | -$939.00K(+92.1%) | -$42.92M(+19.8%) |
| Jun 2004 | - | -$11.92M(+11.6%) | -$53.53M(-0.8%) |
| Mar 2004 | - | -$13.49M(+18.6%) | -$53.09M(+1.8%) |
| Dec 2003 | -$55.09M(+45.2%) | -$16.57M(-43.5%) | -$54.09M(+30.5%) |
| Sep 2003 | - | -$11.55M(-0.6%) | -$77.88M(+11.6%) |
| Jun 2003 | - | -$11.48M(+20.7%) | -$88.05M(+10.0%) |
| Mar 2003 | - | -$14.49M(+64.1%) | -$97.88M(+2.6%) |
| Dec 2002 | -$100.52M(-143.8%) | -$40.36M(-85.9%) | -$100.52M(-34.3%) |
| Sep 2002 | - | -$21.72M(-1.9%) | -$74.83M(-46.1%) |
| Jun 2002 | - | -$21.32M(-24.5%) | -$51.23M(-14.2%) |
| Mar 2002 | - | -$17.12M(-16.7%) | -$44.87M(-8.8%) |
| Dec 2001 | -$41.23M(-23.4%) | -$14.67M(-880.4%) | -$41.23M(-10.6%) |
| Sep 2001 | - | $1.88M(+112.6%) | -$37.29M(+22.8%) |
| Jun 2001 | - | -$14.95M(-10.9%) | -$48.29M(-20.2%) |
| Mar 2001 | - | -$13.49M(-25.7%) | -$40.18M(-20.3%) |
| Dec 2000 | -$33.40M(-87.7%) | -$10.73M(-17.6%) | -$33.40M(-23.2%) |
| Sep 2000 | - | -$9.12M(-33.3%) | -$27.11M(-21.0%) |
| Jun 2000 | - | -$6.84M(-2.0%) | -$22.39M(-8.7%) |
| Mar 2000 | - | -$6.71M(-51.3%) | -$20.60M(-15.8%) |
| Dec 1999 | -$17.80M(-66.4%) | -$4.43M(-0.5%) | -$17.79M(-32.2%) |
| Sep 1999 | - | -$4.41M(+12.7%) | -$13.46M(+4.0%) |
| Jun 1999 | - | -$5.05M(-29.8%) | -$14.02M(-12.4%) |
| Mar 1999 | - | -$3.89M(-3755.4%) | -$12.48M(-17.3%) |
| Dec 1998 | -$10.70M(-694.4%) | -$101.00K(+98.0%) | -$10.64M(+7.0%) |
| Sep 1998 | - | -$4.97M(-41.6%) | -$11.44M(-74.2%) |
| Jun 1998 | - | -$3.51M(-70.8%) | -$6.57M(-84.7%) |
| Mar 1998 | - | -$2.06M(-128.4%) | -$3.56M(-287.1%) |
| Dec 1997 | $1.80M(-53.8%) | -$900.00K(-800.0%) | $1.90M(-70.3%) |
| Sep 1997 | - | -$100.00K(+80.0%) | $6.40M(+20.8%) |
| Jun 1997 | - | -$500.00K(-114.7%) | $5.30M(-27.4%) |
| Mar 1997 | - | $3.40M(-5.6%) | $7.30M(+87.2%) |
| Dec 1996 | $3.90M | $3.60M(+400.0%) | $3.90M(+1200.0%) |
| Sep 1996 | - | -$1.20M(-180.0%) | $300.00K(-80.0%) |
| Jun 1996 | - | $1.50M(>+9900.0%) | $1.50M(>+9900.0%) |
| Mar 1996 | - | $0.00 | $0.00 |
FAQ
- What is Neurocrine Biosciences, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual EBITDA year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Neurocrine Biosciences, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. TTM EBITDA year-on-year change?
What is Neurocrine Biosciences, Inc. annual EBITDA?
The current annual EBITDA of NBIX is $583.00M
What is the all-time high annual EBITDA for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual EBITDA is $583.00M
What is Neurocrine Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, NBIX annual EBITDA has changed by +$225.00M (+62.85%)
What is Neurocrine Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of NBIX is $247.00M
What is the all-time high quarterly EBITDA for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly EBITDA is $247.00M
What is Neurocrine Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, NBIX quarterly EBITDA has changed by +$55.70M (+29.12%)
What is Neurocrine Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of NBIX is $583.30M
What is the all-time high TTM EBITDA for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high TTM EBITDA is $614.00M
What is Neurocrine Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, NBIX TTM EBITDA has changed by -$30.70M (-5.00%)